U.S. resumes funding controversial stem cell research

Fri, 10 Sep 2010 15:48:09 -0400

WASHINGTON (Reuters) - The U.S. government said it was resuming work on controversial human embryonic stem cell research on Friday after an appeals court ruled in its favor.

Risks of old, new diet drugs face U.S. scrutiny

Fri, 10 Sep 2010 15:47:06 -0400

WASHINGTON (Reuters) - The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.

USDA knew of problems at farm behind egg recall: report

Fri, 10 Sep 2010 04:07:37 -0400

BANGALORE (Reuters) - U.S. Department of Agriculture experts knew about sanitary problems at one of the two Iowa farms at the center of a massive nationwide egg recall, but did not notify health authorities, the Wall Street Journal reported.

FDA cracks down on 5 makers of e-cigarettes

Fri, 10 Sep 2010 11:28:42 -0400

CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.

Breastfeeding for a month cuts mom's diabetes risk

Fri, 10 Sep 2010 13:29:52 -0400

NEW YORK (Reuters Health) - Mothers who don't breastfeed their newborns for at least one month are more likely to develop type 2 diabetes at some point in their lives than women who do, a Pennsylvania study finds.

Study backs prostate screening for high risk men

Fri, 10 Sep 2010 11:27:56 -0400

LONDON (Reuters) - Men who have a certain genetic variations that put them at higher risk of prostate cancer may benefit from regular screening for the disease, a study by British scientists found Friday.

UK's NICE wants more data on schizophrenia drug

Fri, 10 Sep 2010 11:26:02 -0400

LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.

FDA cracks down on 5 makers of e-cigarettes

Thu, 09 Sep 2010 17:40:32 -0400

CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.

UK's NICE wants more data on BMS schizophrenia drug

Thu, 09 Sep 2010 19:04:38 -0400

LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.

J&J widens access as cancer drug helps survival

Thu, 09 Sep 2010 19:10:34 -0400

NEW YORK (Reuters) - All patients in a study of a Johnson & Johnson drug for advanced prostate cancer will be offered the medicine after an independent monitoring committee found it demonstrated an improvement in patient survival.